As of 2025-07-19, the Intrinsic Value of Beijing Science Sun Pharmaceutical Co Ltd (300485.SZ) is 0.89 CNY. This 300485.SZ valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y). With the current market price of 13.72 CNY, the upside of Beijing Science Sun Pharmaceutical Co Ltd is -93.50%.
The range of the Intrinsic Value is 0.75 - 1.07 CNY
Based on its market price of 13.72 CNY and our intrinsic valuation, Beijing Science Sun Pharmaceutical Co Ltd (300485.SZ) is overvalued by 93.50%.
Range | Selected | Upside | |
a | |||
DCF (Growth 5y) | (2.14) - (0.60) | (0.96) | -107.0% |
DCF (Growth 10y) | (0.59) - (1.87) | (0.89) | -106.5% |
DCF (EBITDA 5y) | 0.75 - 1.07 | 0.89 | -93.5% |
DCF (EBITDA 10y) | 0.45 - 0.84 | 0.62 | -95.5% |
Fair Value | -1.99 - -1.99 | -1.99 | -114.51% |
P/E | (9.69) - 5.31 | (3.72) | -127.1% |
EV/EBITDA | (1.80) - 1.51 | (0.41) | -103.0% |
EPV | (0.30) - (0.50) | (0.40) | -102.9% |
DDM - Stable | (1.89) - (6.33) | (4.11) | -130.0% |
DDM - Multi | 0.97 - 2.71 | 1.45 | -89.4% |
Market Cap (mil) | 6,608.51 |
Beta | 1.14 |
Outstanding shares (mil) | 481.67 |
Enterprise Value (mil) | 6,537.31 |
Market risk premium | 6.13% |
Cost of Equity | 14.20% |
Cost of Debt | 5.00% |
WACC | 9.19% |